SET and breast carcinoma: Moreover, SET and CIP2A were found to be endogenous inhibitors of PP2A, and SET, CIP2A, and pS62-MYC proteins are commonly overexpressed in human breast cancers (Sablina et al. 2010; Janghorban et al. 2014).